DALLAS, Sept. 15, 2009 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring life sciences company Helicos BioSciences Corp. (Nasdaq:HLCS). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

The investment report on Helicos BioSciences Corp. (Nasdaq:HLCS) should be of particular interest to other life sciences companies: Affymetrix Inc. (Nasdaq:AFFX), Life Technologies Corp. (Nasdaq:LIFE) and Amgen Inc. (Nasdaq:AMGN).

It is available at: http://www.beaconequity.com/i/HLCS

Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity

Helicos BioSciences Corp. (HLCS) engages in the life sciences, focusing on genetic analysis technologies for the clinical diagnostics market. The Company's proprietary technology enables researchers, healthcare enterprises and pharmaceuticals to rapidly analyze large volumes of genetic material by sequencing single molecules of DNA and RNA.

In the report, the analyst notes:

"The market for DNA-based infectious disease tests totals $1.1 billion per year. DNA-based tests have emerged as the standard in oncology and have moved into the research of chronic disease, infectious disease and diseases of aging. Scientists and policymakers believe DNA-based diagnostics will revolutionize medicine in the coming years. ... The potential for the understanding of the disease process at the molecular level enables more effective drug and other therapies. Without the knowledge gained from DNA-based research, medical advances will be stunted and limited to present techniques of treating disease.

"The Company provides the technology to analyze a wide range of genes for the testing of drug and other therapies for the pharmaceutical, biomedical research and diagnostic markets. Additionally, the Company develops technologies to enhance chemistries and consumer products though improving the sequencing throughput."

To read the entire report visit: http://www.beaconequity.com/i/HLCS

See what investors are saying about these stocks at: http://www.stockhideout.com/

BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com

Beacon Equity Disclosure

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

CONTACT:  Beacon Equity Research
          Jeff Bishop
          (469)-252-3505
          press@beaconequity.com